Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10711)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abdelwahab KS, Ahmed Said ZN. Status of hepatitis C virus vaccination: Recent update. World J Gastroenterol 2016; 22(2): 862-873 [PMID: 26811632 DOI: 10.3748/wjg.v22.i2.862] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i2/862.htm |
| Number | Citing Articles |
| 1 |
Reham M. Dawood, Ghada M. Salum, Tawfeek H. Abdelhafez, Reem El Shenawy, Noha E. Ibrahim, Mostafa K. El Awady. Safety and tolerability of mice to repeated subcutaneous injections of a peptide mix as a potential vaccine against HCV infection. Human Antibodies 2019; 27(2): 105 doi: 10.3233/HAB-180354
|
| 2 |
Narotam Narotam. Characterization of Hepatitis C Virus (HCV) Genotypes with Spectrum of its Viral Load. Journal of Analytical & Pharmaceutical Research 2016; 3(3) doi: 10.15406/japlr.2016.03.00058
|
| 3 |
Jinyu Han, Dandan Zhao, Dan Li, Xiaohua Wang, Zheng Jin, Kai Zhao. Polymer-Based Nanomaterials and Applications for Vaccines and Drugs. Polymers 2018; 10(1): 31 doi: 10.3390/polym10010031
|
| 4 |
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak, Anna Jelińska. Hepatitis C – New drugs and treatment prospects. European Journal of Medicinal Chemistry 2019; 165: 225 doi: 10.1016/j.ejmech.2019.01.025
|
| 5 |
Zahra Hasanshahi, Ava Hashempour, Farzane Ghasabi, Javad Moayedi, Zahra Musavi, Behzad Dehghani, Heidar Sharafi, Hassan Joulaei. First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01988-y
|
| 6 |
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. Journal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
|
| 7 |
Mona Razin, Abdel-Rahman B. Abdel-Ghaffar, Germine M. Hamdy, Dina N. Abd-Elshafy, Solaf Kamel, Mahmoud Mohamed Bahgat, Amany Sayed Maghraby. TLR3\TLR7 as Differentially Expressed Markers Among Viral, Nonviral, and Autoimmune Diseases in Egyptian Patients. Viral Immunology 2021; 34(9): 607 doi: 10.1089/vim.2021.0006
|
| 8 |
Kimia Kardani, Azam Bolhassani, Mona Kardani, Elnaz Agi. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders. Journal of Medical Microbiology and Infectious Diseases 2021; 9(3): 122 doi: 10.52547/JoMMID.9.3.122
|
| 9 |
Seroprevalence of Hepatitis B and C Infections Among HIV/AIDS Patients Attending Aminu Kano Teaching Hospital, Kano State, Nigeria. UMYU Journal of Microbiology Research (UJMR) 2017; 2(1): 200 doi: 10.47430/ujmr.1721.029
|
| 10 |
Kimia Kardani, Parya Basimi, Mehrshad Fekri, Azam Bolhassani. Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development. Expert Review of Clinical Pharmacology 2020; 13(9): 1001 doi: 10.1080/17512433.2020.1814743
|
| 11 |
Shahram Jalilian, Seyed Mahmoud Latifi, Manoochehr Makvandi, Ali Teimoori, Azarakhsh Azaran, Mehdi Parsanahad, Gholamabas Kayedani. The Evaluation of Interferon Lambda 4 rs368234815 as a Predictor Factor in Treated Patients with Chronic Hepatitis C Genotype 1a Infection. Indian Journal of Medical Microbiology 2017; 35(2): 262 doi: 10.4103/ijmm.IJMM_16_309
|
| 12 |
Vuyolwethu Khwaza, Buhle Buyana, Xhamla Nqoro, Ruwizhi Ngonidzashe, Opeoluwa O. Oyedeji, Blessing A. Aderibigbe. Polymeric Biomaterials for Healthcare Applications. 2022; : 41 doi: 10.1016/B978-0-323-85233-3.00002-1
|
| 13 |
María Q. Marín, Patricia Pérez, Carmen E. Gómez, Carlos Óscar S. Sorzano, Mariano Esteban, Juan García-Arriaza. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression. Viruses 2018; 10(8): 414 doi: 10.3390/v10080414
|
| 14 |
Mahdi Mahjoub, Smohammad Mahboubi-Rabbani, Rouhollah Vahabpour, Afshin Zarghi, Elham Rezaee, Sayyed Abbas Tabatabai. Discovery of novel HCV inhibitors: design, synthesis and biological activity of phthalamide derivatives. Medicinal Chemistry Research 2022; 31(11): 1916 doi: 10.1007/s00044-022-02947-2
|
| 15 |
Jin-Ching Lee, Chun-Kuang Lin, Chin-Kai Tseng, Yeh-Long Chen, Cherng-Chyi Tzeng, Chih-Hua Tseng. Discovery of 3-Amino-2-Hydroxypropoxyisoflavone Derivatives as Potential Anti-HCV Agents. Molecules 2018; 23(11): 2863 doi: 10.3390/molecules23112863
|
| 16 |
Reza Taherkhani, Fatemeh Farshadpour. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges. World Journal of Hepatology 2017; 9(33): 1239-1252 doi: 10.4254/wjh.v9.i33.1239
|
| 17 |
Noura H Abd Ellah, Hesham M Tawfeek, James John, Helal F Hetta. Nanomedicine as a future therapeutic approach for Hepatitis C virus. Nanomedicine 2019; 14(11): 1471 doi: 10.2217/nnm-2018-0348
|